Dobecure is working on preclinical and clinical studies in disorders where the synthetic inhibitors of fibroblast growth factor (FGF) might be involved, such us age-related macular degeneration, both wet and dry, uveitis, corneal edema and herpetic queratitis, tendinitis and tendinosis, cold sores, otitis and allergic rhinitis.
Actually we have the following international patents
Patent for ophthalmological use, validated in several European countries (Spain, France, United Kingdom, Germany, Italy, Switzerland and the Confederation Helvetica, Portugal).
Otitis and allergic rhinitis
We have applied for the patent in otitis and allergic rhinitis in the European Patent Office.